VIEW PDF 5 August 2020: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it received a notice of allowance for an important US patent application 15/992,270 related to using common wearable sensors to objectively train and adjust the…
Blog Archives
Great Lakes NeuroTechnologies to be Awarded Four Patents for Movement Disorder Monitoring and Therapy Adjustment
VIEW PDF 28 JUL 2020: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it received notices of allowance for four US patents related to movement disorder monitoring and therapy adjustment. These patents will expand GLNT’s patent portfolio of…
Great Lakes NeuroTechnologies Allowed Patent Claims Covering Therapy and Diagnostic Device Combinations
VIEW PDF 17 MAR 2020: Independence, OH – Great Lakes NeuroTechnologies The United States Patent Office issued a notice of allowance and awarded Great Lakes NeuroTechnologies (GLNT) patent claims in application 16/108,746 covering a therapy and diagnostic device combination for…
Great Lakes NeuroTechnologies Introduces KinesiaU™ for Objective Motor Assessment Using a Smartwatch
VIEW PDF 02 May 2019: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it will be introducing the KinesiaU™ motor assessment system [ https://www.KinesiaU.com ] at the American Academy of Neurology Annual Meeting, which is being held in…
Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson’s disease starting transdermal rotigotine patch: A pilot study
Isaacson S, Boroojerdi B, Waln O, McGraw M, Kreitzman D, Klos K, Revilla F, Heldman D, Phillips M, Terricabras D, Markowitz M, Woltering F, Carson S, Truong D Parkinsonism & Related Disorders. 2019 (In Press)
Great Lakes NeuroTechnologies Awarded Two New Patents for Movement Disorders Therapy Adjustment
VIEW PDF 15 OCT 2018: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it has been awarded two new U.S. Patents. The new patents include 10,085,689 (Device and method for monitoring and assessment of movement disorder symptoms) issued…
The impact of a wearable device on Parkinson’s disease motor symptom management in patients starting rotigotine transdermal patch
S. Isaacson, B. Boroojerdi, K. Klos, S. Carson, M. Markowitz, D. Heldman, M. Phillips, D. Terricabras, F. Woltering, D. Truong. Movement Disorders Society Annual Meeting, 2018, Hong Kong.
Great Lakes NeuroTechnologies Receives Two New NIH SBIR Grant Awards
VIEW PDF 1 OCT 2018: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it has been awarded two new Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH), which will provide nearly $2 Million…
Using Objective Measurement Via Wearable Sensors To Evaluate Real-world Effectiveness Of Carbidopa/Levodopa Enteral Suspension For Managing Motor Fluctuations: PROviDE Study Design And Baseline Characteristics
R. Pahwa, R. Dorsey, I. Pan, S. van Norman, T. Marshall, D. Heldman, Y. Jalundhwala. 70th Annual Meeting of the American Academy of Neurology, Los Angeles, CA, 2018
Wearable Motion Quantification and Electronic Diaries for Long-Term Monitoring of Parkinson’s Disease
A. Hadley, E. Urrea-Mendoza, N. Mennucci, C. Zimmerman, J. Giuffrida, Z. Mari, M. Burack, I. Itin, F. Revilla, D. Heldman. 70th Annual Meeting of the American Academy of Neurology, Los Angeles, CA, 2018